The TBS Bone Health Ecosystem

Univ.-Prof. Dr. Karen Hind
VP of Clinical Affairs, Research & innovation, Medimaps | University Professor

Thursday, April 16, 2026 at 17:41 • Auditorium 1

Prediction of incident fractures using the AI-based TBS Reveal* Bone Fragility Index: a Bayesian survival analysis

Guillaume Gatineau
Data and AI Scientist, Medimaps

Saturday, April 18, 2026 at 11:35 • OC26

P202

Decreased kidney function is associated with lower l1 density on opportunistic computed tomography: comparison of different clinically available tools

A. Jančuška, R. Králik, J. Payer, M. Kužma

P241

Machine learning for osteoporosis risk prediction in Thailand’s aging population

A. P. Phruetthiphat, P. Pinijprapa, D. R. Homsapaya

P287

Bone profile in postmenopausal women with adrenal tumors according to cortisol secretion status: a cross-sectional study

A.-I. Trandafir

P293

Bone status in a young female with primary amenorrhea

A.-M. Gheorghe, A.-I. Trandafir, O.-C. Sima, M. Costachescu, A. Tomacinschii, L. Suveica, E. Petrova

P300

Overlap between persistent primary hyperparathyroidism, osteoporosis and bone metastases: management challenges

A.-M. Gheorghe, E. Petrova, M. Costachescu, O.-C. Sima, A.-I. Trandafir

P306

Osteopenia in a patient with newly detected breast malignancy: challenges of management

M. Costachescu, O.-C. Sima, E. Petrova, A.-M. Gheorghe, A.-I. Trandafir

P331

The added value of Trabecular Bone Score (TBS) in evaluating fracture risk among polish women

B. Jaszczyk, A. Nowakowska – Płaza, B. Stypińska, I. Sudoł-Szopińska, P. Głuszko, R. Olszewski

P412

Bone density response to romosozumab is maintained in the oldest old (≥80 years): real-world data from the UK

C. Rakieh, D. Powell, T. Roberts, J. Cole, C. Mennan

P455

Bone health and risk of fractures in females with osteosarcopenia

D. Kurylo, N. Grygorieva, A. Musiienko

P503

Fracture risk assessment in a cohort of 112 male patients undergoing radical cystectomy and ileal urinary diversion

E. Casado, C. Eyre, C. Piqué, M. Cabanillas, J. Muñoz, C. Centeno, L. De Verdonces, L. Grubicy, A. Domínguez

P504

Performance of frax® to guide dxa use and anti-osteoporotic treatment in men with ileal urinary diversion after radical cystectomy: underestimation of fracture risk and the added value of bmd and TBS adjustments

E. Casado, C. Piqué, C. Eyre, J. Muñoz, C. Centeno, L. De Verdonces, M. Cabanillas, L. Grubicy, A. Domínguez

P551

Differential effects of osteoporosis therapies on Trabecular Bone Score: a systematic review and meta-analysis

E. Shevroja, D. Vieira, E. Gonzalez Rodriguez, O. Lamy, K. Hind, D. Hans

P583

Bone profile in patients after liver transplantation: a cross-sectional analysis

F. Alam, O. Alsaed, I. Abdulmomen, N. Abdulla, A. Lutf, S. Al Emadi

P672

The role of the cyp1a1 gene in long term glucocorticoid-related adverse effects

H. Florez, E. Gonzalez, K. Cajiao, J. L. Carrasco, J. Hernández-Rodríguez, S. Prieto-González, M. C. Cid, A. Monegal, N. Guañabens, P. Peris

P826

Systemic inflammation predicts bone fragility in adult-onset still’s disease: a cross-sectional analysis

J.-W. Kim, J.-Y. Jung, H.-A. Kim, Y. J. Choi

P833

Balancing the “do no harm” principle in glucocorticoid therapy: a critical assessment of glucocorticoid induced osteoporosis

S. Delezan, L. Drazic, K. Boskovic, J. Zvekic – Svorcan, N. Nenadov Jovanovic

P834

Association between vertebral body heights and osteodensitometry findings

S. Delezan, J. Zvekic – Svorcan, T. Jankovic, N. Bastaja, T. Tasic, T. Bjeletic, K. Boskovic

P843

Refining osteoporosis classification using BMD t-score-adjusted for Trabecular Bone Score (TBS): real world evidence in women aged ≥40 years

K. Hind, A. Walstra, D. Krueger, N. Binkley, F. Thimary, A. Fahrleitner-Pammer, M. Küzma, J. Payer, K. Chun, A. Sherman, K. Jones, J. Bencardino, G. Guglielmi, M. Davies, M. De Gruttola, G. Gatineau, D. Hans

P844

Clinical and economic impact of Trabecular Bone Score (TBS) in osteoporosis management

F. Borgström, J. Kanis, K. Hind, Z. Németh, M. Davies, D. Hans

P923

Current glucocorticoid use is associated with increased cortical porosity, reduced physical performance and increased fracture risk in older women

M. Zoulakis, L. Johansson, A. Pihl, K. Axelsson, M. Lorentzon

P943

Associations between functional performance and Trabecular Bone Score in older women with sarcopenia

D. Kurylo, N. Grygorieva, A. Musiienko

P960

Imaging spectrum of bone involvement in patients with hematological diseases: a rheumatology perspective

L. Suarez-Zorrilla, E. Garmendia-Sanchez, C. Modesto Caballero

P998

Study of bone architecture in lung transplant recipients

M. Pascual, A. Cabrera, N. Boix, M. Barceló

P1008

UK adult reference curves for Trabecular Bone Score (TBS osteo v4)

M. G. Swainson, K. Hind, M. Davies, A. Walstra, D. Hans, M. Bukhari

P1014

Centralized DXA imaging workflow for standardized assessment in multicentre clinical studies

O. Kubassova, A. Singareddy, M. Clark, R. Hagoug

P1022

Trabecular Bone Score (TBS) in pediatric females with anorexia nervosa

J. Briody, A. Waltra, K. Hind, M. Davies, D. Hans

P1023

Philippine  Adult Reference Values for Trabecular Bone Score (TBS Osteo v3)

J. Li-Yu, M. Degruttola, M. Davies, A. N. H. Walstra, K. Hind, S. Lekamwasam, D. Hans

P1061

Muscle weakness and bone microarchitecture in postmenopausal women

M. D. M. Muñoz-Gomez, M. Hayón-Ponce, D. Blanquez Martinez

P1072

Microarchitectural bone deficits in adults with hypophosphatasia

M. Kužma, J. Payer, A. Jančuška, V. Zikán, H. Resch, J. Haschka, R. Kocijan

P1120

Study of bone microarchitecture in lung transplant patients: pre transplant analysis

M. Pascual-Pastor, A. Cabrera, N. Boix Martí, M. Barceló Bru

P1122

Associations of visceral adiposity index and lipid accumulation product with bone health status in men aged 50 and over: a cross-sectional analysis of bushehr elderly health (beh) program

S. Mohseni, K. Khalagi, A. Amanollahi, N. Fahimfar, M. Pejman Sani, B. Larijani, I. Nabipour, A. Ostovar

P1131

Romosozumab and microarchitecture: TBS lumbar t-score detects change beyond bmd

A. Zúñiga-Vera, M. Sanabria-Hernández, M. Robustillo Villarino

P1133

Integrating bone quality and systemic health: romosozumab-driven microarchitectural gains and their relationship with inflammation and cardiovascular risk

M. Robustillo-Villarino, A. Zúñiga-Vera, M. Sanabria Hernández

P1134

Romosozumab in patients with chronic kidney disease and very high fracture risk: real-world evidence to guide therapeutic decision-making

M. Robustillo-Villarino, A. Zúñiga-Vera, M. Sanabria Hernández

P1135

Baseline hyperparathyroidism and prior bisphosphonate exposure identify a clinical profile associated with response to romosozumab in patients at very high fracture risk

M. Robustillo-Villarino, A. Zúñiga-Vera, M. Sanabria Hernández, P. Martínez-Fernández

P1136

Blood cell count–derived inflammatory ratios and skeletal response to romosozumab: a multicenter realworld cohort

A. Zúñiga-Vera, M. Sanabria-Hernández, L. Gifre-Sala, A. Naranjo-Hernández, S. Ojeda, E. Naveda, R. Durán Rodríguez, M. Robustillo-Villarino

P1137

TBS for monitoring osteoporosis during romosozumab: feasibility, responsiveness and least significant change in a multicenter cohort

M. Robustillo-Villarino, A. Zúñiga-Vera, M. Sanabria Hernández, A. Naranjo-Hernández, L. Gifre-Sala, R. Durán-Rodríguez, E. Naveda, S. Ojeda

P1186

Fracture risk prediction in kidney transplant recipients: a systematic review

M.-J. Bégin, A. Hang, A. Bergeron, A. Rakel, L.-G. Ste Marie, F. Mac-Way, H. Cardinal, M. Chassé

P1208

Osteoporosis, Trabecular Bone Score and angina pectoris: evidence from bushehr elderly health (beh) program

K. Sotoodeh, N. Fahimfar, F. Mogharrar, E. Hesari, A. Soltani, K. Khalagi, M. Sanjari, R. Heshmat, M. J. Mansourzadeh, I. Nabipour, A. Ostovar, B. Larijani

P1209

The osteoporosis diagnosis and treatment gaps in Iranian older adults: bushehr elderly health (beh) program

M. Sanjari, N. Fahimfar, E. Hesari, H. Yarmohammadi, S. Shahrousvand, K. Khalagi, P. Zarepour, S. Gharibzadeh, M. J. Mansourzadeh, G. Sahafiei, I. Nabipour, B. Larijani, A. Ostovar

P1219

Bone mineral density and dxa-based 3d analysis of the hip cortical and trabecular bone in postmenopausal women with osteosarcopenia

N. Grygorieva, M. Bracco, N. Zaverukha, L. Humbert, D. Kurylo, A. Iniushyna

P1270

Secondary hyperparathyroidism and bone health *bmd and TBS)): bushehr elderly health program

N. Panahi, F. Sehatpour, Y. Waladi, K. Khalagi, N. Noushin, I. Nabipour

P1284

Association of Trabecular Bone Score with immunological parameters in women with rheumatoid arthritis

M. Kozyreva, N. Demin, N. Toroptsova

P1285

Uric acid level, bone mineral density and Trabecular Bone Score in rheumatoid arthritis patients

M. Kozyreva, N. Demin, N. Toroptsova

P1296

Population-specific reference data for bone mineral density and Trabecular Bone Score (TBS v4) in healthy Qatari adults

O. Alsaed, F. Alam, I. Abdulla, I. Abdulmomen, A. Lutf, K. Hind, M. De Gruttola, M. Davies, S. Al Emadi, D. Hans

P1320

Vitamin d and bone metabolism in non alcoholic, non-viral liver cirrhosis

O. Spasskaya, A. Gorbacheva, I. Tikhonov, A. Kairieva, E. Litvinova, H. Bagirova, A. Eremkina, N. Mokrysheva

P1335

Decision of anti-osteoporotic therapy re-initiation after drug holiday: should high vitamin d-related low pth count?

O.-C. Sima, M. Costachescu, A.-M. Gheorghe, A.-I. Trandafir, E. Petrova, A. Dumitrascu

P1338

Decision of re-starting therapy after bisphosphonates drug holiday in a postmenopausal patient with a history of toxic multinodular goiter

O.-C. Sima, V. Salaru, L. Suveica, A.-M. Gheorghe, M. Costachescu, A.-I. Trandafir

P1340

Musculoskeletal involvement in a male with acromegaly: the relationship with the pituitary disease control

O.-C. Sima, V. Salaru, A.-M. Gheorghe, A.-I. Trandafir, M. Costachescu, L. Suveica

P1341

Pitfalls of adherence to the anti osteoporosis medication across real life setting

O.-C. Sima, L. Gitu, A.-I. Trandafir, A.-M. Gheorghe, M. Costachescu, L. Suveica

P1343

Recurrent rib fractures under subcutaneous medication against osteoporosis in a patient with systemic sclerosis: the issues of severe calcinosis cutis

O.-C. Sima, L. Suveica, A.-I. Trandafir, M. Costachescu, A.-M. Gheorghe, A. Topa

P1351

Trabecular Bone Score by Tanner Stage in Children and Adolescents from Mexico City

M. A. Guagnelli, D. Lopez-González, A. N. H. Walstra, K. Hind, D. Hans, P. Clark

P1350

Trabecular Bone Score and areal bone mineral density accrual in relation to peak bone mass in children from Mexico city

M. A. Guagnelli, D. Lopez-González, A. N. H. Walstra, K. Hind, D. Hans, P. Clark

P1352

Trabecular Bone Score (TBS) at the hip reflects 3D bone microarchitecture: a micro-ct validation study

P. Eghbalishamsabadi, G. Gatineau, M. De Gruttola, M. Swainson, M. Davies, A.
Walstra, K. Hind, D. Hans

P1353

Trabecular Bone Score (TBS) at the hip demonstrates high ex-vivo and in-vivo reproducibility

P. Eghbalishamsabadi, G. Gatineau, M. De Gruttola, M. Swainson, M. Davies, A.
Walstra, K. Hind, D. Hans

P1432

Traumatic tibial plateau fracture in a patient with osteopoikilosis: unveiling the bone quantity-quality paradox and metabolic activity – a case report

R. Suwanaratana, N. Chanalithichai, P. Thanindratarn

P1497

The association of 25(oh)d3 concentration with bone mineral density, bone turnover markers and biochemical parameters in psoriatic arthritis

S. Grazio, A. Vrtarić, N. Nikolac Gabaj, F. Grubisic, M. Bozovic, M. Punda, H. Skala Kavanagh, I. Doko Vajdic1 L. Prtenjaca

P1602

Significant bone mineral density recovery following teriparatide therapy in a 30-year-old primiparous woman with multiple vertebral fractures

M. T. Tsagareli, E. G. Giorgadze, T. S. Sulikashvili, T. Z. Zerekidze, T. B. Bakhtadze

P1610

The evaluation of DXA parameters in patients with non-alcoholic fatty liver disease

T. Tsoriev, I. Skripnikova, E. Mamutova, A. Sheptulina, A. Yafarova

P1702

How common is it? high and very high-risk fracture rates among patients with a non-osteoporotic range bone mineral density in a DXA database from a tertiary medical center

Y. Eden-Friedman, I. Vered, N. Tripto, N. Minsky, Y. Levy-Shraga, P. Rotman-Pikielny, L. Tripto-Shkolnik

P1703

Trabecular Bone Score (TBS): a critical complementary tool to DXA for enhanced fracture risk stratification in clinical practice

Y. El Miedany, M. El Gaafary, M. Toth, W. Hassan, S. Mahran, M. H. Abu Zaid, S. Tabra, A. El Miedany, W. Elwakil

P1704

Assessing bone microarchitecture: romosozumab induces favorable changes in Trabecular Bone Score compared to anti-resorptive therapy

Y. El Miedany, M. Toth, W. Elwakil, M. El Gaafary, A. El Miedany